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MICs considered to be in the susceptible range (≤2.0 g/ml) but420 15th ICID Abstracts / International Journa
nd anti-biogrampattern of enterococci species collected in Shahid
ohammadi hospital.
Methods: In this descriptive cross sectional study, performed
etween March 2010 and March 2011, about 4487 various clinical
pecimens of hospitalized patients were investigated for entero-
occi species. The specimens were cultured on Blood agar, EMB
nd Chocolate agar. Suspicious colonies were identiﬁed by Gram
taining, growth in bile salt and NaCl 6.5% media. Antibiogram pat-
erns were determined by Kirby-Bauer method on Mueller-Hinton
edium. Clinical and microbiological data was analyzed by SPSS16
oftware.
Results: A total of 55 (4.47%) species of enterococci was iso-
ated from 1229 positive cultures.Enterococci was mostly (34.5%)
btained from old age (>65y) patients and internal (>50%) wards
specially internal 1 (23.6%). Urinary tract (67.3%) and wounds
10.9%)were the twomajor sitesof infection.Nitrofurantoin (80.6%)
ndvancomycin (75%)weremost effective antibiotics, respectively.
high rate of resistance was observed to cephalosporines (78.6%)
nd Aminoglycosides (67.4%). Mortality rate was 16.3% with ente-
ococcal infections.
Conclusion: In our study the most susceptible antibiotics were
itrofurantoin and vancomycin, which aligns with some other
tudies. Because of high frequency and multi- drug resistance of
nterococci species, continuous monitoring of antimicrobial sus-
eptibility and strict adherent to infection guidelines are essential
o prevent and eliminate enterococci infections.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.580
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ntibiotic resistance of Pseudomonas aeruginosa clinical iso-
ates from Greece and Romania during the year 2009
.-L. Pandrea1, L.M. Junie2, E. Kalman3, M. Papadogianni4, G.
leuraki5, E. Papadomanolaki5, E. Vardaki6, L. Kalogeraki4, I.
agoudaki7, B. Tsagli 8, S. Kastanakis9
University of Medicine and Pharmacy, Cluj, Romania
University of Medicine and Pharmacy, 40023, Romania
Regional Institute of Gastroenterology – Hepatology, Cluj, Romania
Saint George general hospital, Chania, Greece
St. George General Hospital Chania, Chania, Greece
Saint George general hospital, Chania, Greece
Saint George general hospital, Chania, Greece
Saint George general hospital, Chania Greece„ Chania, Greece
Saint George General Hospital, Chania, Greece
Background: One of the most difﬁcult problems in hospitals
s the appearance of an increased number of Pseudomonas antibi-
tic resistant strains. It is characterised by intrinsic and acquired
esistance tomany antibiotic classes causing the treatment of these
nfections difﬁcult.
Methods: In this study we examined antibiotic resistance rates
f clinical isolates of P. aeruginosa recovered in Saint George Gen-
ral Hospital of Chania and Regional Institute of Gastroenterology
Hepatology of Cluj Napoca.
From Greece we investigated a total of 246 strains of P.
eruginosa isolated fromall cultures (urine, blood, trauma, etc) dur-
ng 2009, from all clinics including the ICU and 24 strains isolatedfectious Diseases 16S (2012) e317–e473
in Cluj Napoca from different samples. Strains from Romania were
collected fromnosocomial infections, inanational surveillancepro-
gram and all strains were collected from ICU. The identiﬁcation to
the species level was achieved by standard procedures and by the
automated system Vitek2 Biomerieux. The susceptibility tests of
isolates were performed by disk diffusion method according to the
CLSI criteria and by the Vitek2 system Biomerieux, using a panel of
29 antibiotics.
Results: The results are presented in the table that follows.
Antibiotics % Resistance of
P.aeruginosa In
Greece
% Resistance of
P.aeruginosa In
Romania
TCC ticarcillin/clavulanic acid 36.7% 87.5%
TZP piperacillin/tazobactam 16.7% 87.5%
CAZ ceftazidime 17.9% 91.7%
FEP cefepime 20.7% 91.7%
IPM imipenem 25.7% 79.1%
MEM meropenem 23.5% 79.1%
COL colistin 2.5% 8.33%
CIP ciproﬂoxacin 36.1% 79.2%
AMK amikacin 18% 80%
InGreece, 23of the isolates fromICU,were susceptible to colistin
only (9.3%) and resistant to all antibiotics. In Romania, 15 of the
isolateswere susceptible to colistin only (62.5%) and2 isolateswere
resistant to all antibiotics (8.33%).
Conclusion: In Greece, amikacin and ceftazidime have
remained active against the majority of P.aeruginosa clinical iso-
lates. Results from Romania could reﬂect the implication of some
hospital multi resistant Pseudomonas strains in nosocomial infec-
tions. Carbapenems should be used with caution due to elevated
percentage of resistance against this class of antibiotics. Colistin
is effective against multidrug resistant strains. Antibiotic policy in
combination with infection-control measures are needed to pre-
vent the spread of multidrug resistant and panresistant strains in
the hospital.
http://dx.doi.org/10.1016/j.ijid.2012.05.581
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Current status of Glycopeptide intermediate and heterogenous
Glycopeptide intermediate Staphylococcus aureus and their pre-
vailing susceptibility pattern at two tertiary care hospitals of
Pakistan
F. Kaleem1, J. Usman2, S. Amanat3
1 Rawal Institute of Health Sciences, Islamabad, Pakistan
2 Army Medical College, National University Of Sciences and Technol-
ogy, Rawalpindi, Pakistan
3 PAEC General Hospital, Islamabad, Pakistan
Background: Glycopeptides have been used widely to treat
methicillin resistant Staphylococcus aureus (MRSA) infections.
Until recently vancomycin resistance among gram-positive bac-
teria had been thought to be uncommon but Glycopeptide
intermediate S. aureus (GISA) and heterogenous GISA (hGISA) have
been reported from various parts of world. Strains of hGISA havecontain a subset of the bacterial population that expresses the
resistance phenotype.This study has been done to evaluate the
current status of glycopeptides intermediate and heterogenoiously
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ntermediate strains of MRSA. Suscpetibility pattern has also been
tudied to formulate an effective, inexpensive and easily adminis-
ered empirical therapy for GISA and hGISA.
Methods: Three hundred and Forty seven MRSA isolated from
he clinical specimens of Allied hospitals of AMC/NUST and PAEC
eneral Hospital, Pakistan were subjected to the determination of
ancomycin minimum inhibitory concentration (MIC) and isolates
aving vancomycinMIC≥1g/mlwere subjected todetermination
f Glycopeptide resistance detection (GRD) using Etest. Suscepti-
ility pattern of all the isolates were recorded using Kirby baur
isc diffusion method and MIC for linezolid, daptomycin, chloram-
henicol, minocycline and tigecycline using E-strips. MIC 50 and
IC 90 were calculated
Results: All isolates were sensitive to vancomycin but 197 iso-
ates showed higher MICs and 6 turned out to be heterogenous
lycopeptide intermediate (h GISA) strains.
All the isolated organisms were highly susceptible to linezolid
98.3%), daptomycin (100%), chloramphenicol (96%), minocycline
95.7%) and tigecycline (94.8%).
Conclusion: Signiﬁcant number of isolates having MIC of van-
omycin equal to or more than 1 ug/ml have been isolated and
hese can turn out to be GISA/h GISA. Vancomycin Susceptibility
reakpoints as indicated by CLSI should be reevaluated because
hat doesn’t cover GISA/h GISA isolates. This study suggests that
inezolid, chloramphenicol, minocycline, daptomycin and tigecy-
line have high in vitro efﬁcacy for MRSA infections. Prescribing
ntibiotics other than glycopeptides for MRSA infections will min-
mize the chances of emergence of GISA. Good hospital infection
ontrol measures prove to be the main stay against these infec-
ions because antibiotics can never be an effective alternative to
ood medical practice.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.582
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ossible antagonism with use of ceftaroline and rifampin to
reat methicillin-resistant Staphylococcus aureus infection
. Sundareshan1, J. Modi2, S. Bergman3, J. Koirala1,∗
Southern Illinois University School of Medicine, Springﬁeld, IL, USA
SIU school of medicine, Springﬁeld, il, USA
Southern Illinois University School of Pharmacy, Edwardsville, IL, USA
Background: A 57 year old male was seen in the hospital for
ight shoulder septic arthritic with methicillin resistantStaphy-
ococcus aureus(MRSA). He was treated with arthroscopic
ebridement and intravenous vancomycin until susceptibilities
ere available. The minimum inhibitory concentration (MIC) for
ancomycin was 1.5 mcg/ml, therefore the patient was discharged
ome on 6mg/kg of daptomycin once daily to be given for 4 weeks.
he MIC of daptomycin was not checked at that time. Patient
eturned for follow up in 3 weeks and complained of persistent
ever and low back pain. Blood cultures were drawn that grew
RSA again. Spinal imaging revealed lumbar diskiitis. We present
ere a case where ceftaroline was used for treatment along with
ifampin to treat a highly resistant strain of MRSA and the results
f our laboratory tests.fectious Diseases 16S (2012) e317–e473 e421
Methods: Laboratory tests performed on the isolate of MRSA
from blood cultures revealed a high MIC of daptomycin that was
in the resistant range. There was now also a creep noted in the
MIC of vancomycin. The patient’s therapy was changed to ceftaro-
line which resulted in negative blood cultures within 24 hours
of initiating therapy. Serum inhibitory concentration (SIC) and
serum bactericidal concentration (SBC) were performed using the
patient’s serum prior to a dose of ceftaroline after steady state
(trough). Rifampinwas added to therapy after reviewing the results
as shown below in table 1. The SIC and SBC were repeated when he
was treated with a combination of ceftaroline and rifampin.
Results: MIC using E-
tests(mcg/ml)
SIC SBC
Vancomycin 2.0 Not indicated Not indicated
Daptomycin 3.0 Not indicated Not indicated
Ceftaroline 0.38 1:8 dilution 1:16 dilution
Ceftaroline and rifampin – 1:16 dilution Not achieved
Conclusion: Even with the availability of newer antibiotics in
the United States with activity against MRSA, treatment of MRSA
infections (particularly bloodstream infections) can be suboptimal.
Frequent laboratory testing with SIC and SBC may be necessary
even in theabsenceofnegativebloodcultures as apreemptivemea-
sure to detect impending clinical failure. The SIC and SBC results
with the combination of ceftaroline and rifampin suggest antag-
onism between the two antibiotics. Further laboratory tests are
necessary to establish that. This patient was successfully treated
with quinupristin/dalfopristin for 6 weeks.
http://dx.doi.org/10.1016/j.ijid.2012.05.583
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In vitro antimicrobial activity of colistin in combination with
rifampicin against carbapenem-resistant Acinetobacter bau-
mannii
K. Kongsanae1,∗, P. Naenna1, C. Dhiraputra2, A. Leelarasamee2,
P. Pongpech1
1 Chulalongkorn University, Bangkok, Thailand
2 Mahidol University, Bangkok, Thailand
Background: The in vitro antimicrobial activity of either col-
istin or rifampicin could be increased in the form of combination
between both drugs.
Methods: Thirty carbapenem-resistant A. baumannii isolates
from Bumratnaradoon Hospital between April 2007 and May 2009
were included in this study. Antimicrobial susceptibility tests
were performed by both Kirby-Bauer disk diffusion and Agar dilu-
tion methods. Synergy effect of the combination of colistin and
rifampicin was determined by checkerboard method. In addition,
the time-kill study was used to determine the bactericidal activity
at 0.5×MIC and 1×MIC of either colistin or rifampicin alone and the
combination of both agents. Morphological cell changes of the bac-
teria after growth in the media plus antimicrobials were observed
by using scanning electron microscopy.Results: Susceptibility testing of 12 antimicrobial agents against
carbapenem-resistant A. baumannii showed that all 30 isolates
were resistant to meropenem, imipenem and rifampicin, while
96.7% of these isolates were resistant to cefepime, ceftazidime,
